Insulet Corporation
Clinical trials sponsored by Insulet Corporation, explained in plain language.
Insulet Corporation
PODD
NASDAQ
A medical device company known for its tubeless insulin pump systems.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Smart insulin pump aims to simplify diabetes management Results expected Dec 2026 (estimated)
- New insulin algorithm aims to simplify diabetes management Results expected Dec 2026 (estimated)
- New insulin pump aims to tame blood sugar swings Results expected Feb 2027 (estimated)
- Thousands to track omnipod 5 in daily life: will the smart pump deliver on its promise? Results expected Jun 2027 (estimated)
- New study puts omnipod 5 to the test in Real-World diabetes management Results expected Jul 2027 (estimated)